253 related articles for article (PubMed ID: 24951459)
1. Modern mammography screening and breast cancer mortality: population study.
Weedon-Fekjær H; Romundstad PR; Vatten LJ
BMJ; 2014 Jun; 348():g3701. PubMed ID: 24951459
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
5. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.
Hofvind S; Ursin G; Tretli S; Sebuødegård S; Møller B
Cancer; 2013 Sep; 119(17):3106-12. PubMed ID: 23720226
[TBL] [Abstract][Full Text] [Related]
7. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
8. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer mortality in Norway after the introduction of mammography screening.
Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
Sebuødegård S; Botteri E; Hofvind S
J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
[TBL] [Abstract][Full Text] [Related]
11. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the Norwegian breast cancer screening program.
van Luijt PA; Heijnsdijk EA; de Koning HJ
Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
[TBL] [Abstract][Full Text] [Related]
13. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
[TBL] [Abstract][Full Text] [Related]
14. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort.
Van Ourti T; O'Donnell O; Koç H; Fracheboud J; de Koning HJ
Int J Cancer; 2020 Apr; 146(8):2201-2208. PubMed ID: 31330046
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
17. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
[TBL] [Abstract][Full Text] [Related]
18. Limitations in the Effect of Screening on Breast Cancer Mortality.
Beau AB; Andersen PK; Vejborg I; Lynge E
J Clin Oncol; 2018 Oct; 36(30):2988-2994. PubMed ID: 30179570
[TBL] [Abstract][Full Text] [Related]
19. Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme.
Bhargava S; Tsuruda K; Moen K; Bukholm I; Hofvind S
J Med Screen; 2018 Sep; 25(3):155-161. PubMed ID: 29059006
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]